Dolby Laboratories, Inc. (NYSE:DLB) Shares Purchased by Amundi

Amundi boosted its stake in Dolby Laboratories, Inc. (NYSE:DLB) by 44.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,594 shares of the electronics maker’s stock after acquiring an additional 1,417 shares during the quarter. Amundi’s holdings in Dolby Laboratories were worth $354,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. boosted its stake in Dolby Laboratories by 18.5% during the 3rd quarter. Victory Capital Management Inc. now owns 14,665 shares of the electronics maker’s stock worth $1,122,000 after purchasing an additional 2,288 shares during the last quarter. Empowered Funds LLC boosted its stake in Dolby Laboratories by 21.8% during the 3rd quarter. Empowered Funds LLC now owns 7,528 shares of the electronics maker’s stock worth $576,000 after purchasing an additional 1,348 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in Dolby Laboratories by 496.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 102,223 shares of the electronics maker’s stock worth $7,823,000 after purchasing an additional 85,093 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in Dolby Laboratories during the 3rd quarter worth $93,000. Finally, Advisors Asset Management Inc. boosted its stake in Dolby Laboratories by 26.8% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,560 shares of the electronics maker’s stock worth $272,000 after purchasing an additional 753 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on DLB. Rosenblatt Securities reaffirmed a “buy” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday, January 30th. StockNews.com cut shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 31st. Finally, Barrington Research reiterated an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, February 13th.

Dolby Laboratories Stock Down 1.1 %

NYSE DLB opened at $80.94 on Friday. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.66. The business’s fifty day simple moving average is $82.16 and its 200-day simple moving average is $77.79. The firm has a market cap of $7.72 billion, a PE ratio of 29.76 and a beta of 1.01.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Stockholders of record on Tuesday, February 11th were issued a dividend of $0.33 per share. The ex-dividend date was Tuesday, February 11th. This represents a $1.32 annualized dividend and a dividend yield of 1.63%. Dolby Laboratories’s dividend payout ratio is presently 48.53%.

Insider Transactions at Dolby Laboratories

In related news, CMO Todd Pendleton sold 18,121 shares of the business’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total value of $1,517,633.75. Following the sale, the chief marketing officer now directly owns 37,290 shares in the company, valued at approximately $3,123,037.50. The trade was a 32.70 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Mark Andrew Sherman sold 40,000 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the completion of the sale, the executive vice president now owns 62,397 shares in the company, valued at approximately $5,296,257.36. This trade represents a 39.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 65,121 shares of company stock worth $5,501,324 in the last quarter. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.